Stem-cell implants restore vision in patients with corneal stem cell deficiency

Researchers successfully tested the safety and preliminary efficacy of stem-cell-derived corneal implants, showing promise for restoring vision in patients with severe corneal damage.

Bluebird snags more outcomes-based coverage for its $3M+ sickle cell gene therapy

A second outcomes-based agreement with an unidentified payer is now in the books for bluebird bio’s new $3.1 million sickle cell gene therapy, the company

January 5, 2024

Ochre Bio CEO Jack O’Meara steps down, outlines plans for next startup

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 17, 2024

Three hospitalized in early morning motorcycle crash on I-270 in Commerce City – The Cannabist

Two motorcycles collided on westbound Interstate 270 in Commerce City early Saturday morning, sending three people to the hospital. The post Three hospitalized in early

June 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.